Valve Thrombosis After Transcatheter Mitral Valve Replacement
Transcatheter mitral valve replacement (TMVR) is a therapeutic option for patients with contraindication or high risk for surgical treatment and failed surgical bioprosthesis or annuloplasty, or even calcific mitral valve disease (1,2). Two of the 3 patients discussed here were asymptomatic at diagn...
Gespeichert in:
Veröffentlicht in: | Journal of the American College of Cardiology 2016-10, Vol.68 (16), p.1814-1815 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Transcatheter mitral valve replacement (TMVR) is a therapeutic option for patients with contraindication or high risk for surgical treatment and failed surgical bioprosthesis or annuloplasty, or even calcific mitral valve disease (1,2). Two of the 3 patients discussed here were asymptomatic at diagnosis, and therefore, this complication may remain undiagnosed unless echocardiographic follow-up is systematically performed. [...]only a mild increase of transmitral gradient was observed in 2 cases. [...]thrombosis of a THV may be overlooked if only TTE is performed. |
---|---|
ISSN: | 0735-1097 1558-3597 |
DOI: | 10.1016/j.jacc.2016.07.757 |